Insulet Corporation management check

PODD · Health Care · Health Care Equipment · CEO Ashley McEvoy

Filings as of

32
Management score, ranked 479th of 487 · 59th of 60 in Health Care3 good · 1 to watch · 3 flaggedStrongest: dilution · Weakest: stable leadership · Best and worst run in Health Care →

The seven checks

  • Good

    Have owners done well?

    Beat its chosen peersOwners$111Peers$99

    What $100 became since fiscal 2021

    6566th
    Detail

    $100 invested at the start of fiscal 2021 grew to $111, against $99 for the peer group the company picked itself.

  • Watch

    Does pay follow performance?

    Pay only loosely tracked returns20212025

    Pay actually paid $100 value, each on its own scale

    6220th
    Detail

    Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.23 with shareholder return. 1 means pay moved in step; below 0, the opposite way.

  • Flag

    What does the CEO cost owners?

    7.6% of net income

    $18.9m pay · $247.1m net income, FY2025

    0.1%1%3%10%
    016th
    Detail

    $18.9m of reported pay in fiscal 2025, against $247.1m of net income.

  • Good

    Do they own the stock?

    Insiders are buying

    23,731 shares ≈ $3.5m

    0.1y1y5y20y100y

    6 mo: ▲ $1.1m bought · ▼ $60k sold

    2022nd
    Detail

    The CEO holds 23,731 shares, directly or through trusts (unvested awards not counted): about 0.2 years of pay. 3 insiders bought $1.1m on the open market in the last six months, with their own money, near the lows. Sales: $60k.

  • Good

    Are owners being diluted?

    Share count shrinking2021 · 69m2025 · 72m

    Diluted shares −1.2% a year; flagged above +2%

    0%10%20%

    Stock pay 2.3% of revenue

    6555th
    Detail

    Diluted shares changed -1.2% a year over the last three fiscal years. Stock-based pay was 2.3% of revenue in the latest year.

  • Flag

    Is leadership stable?

    3 CEOs in the pay table

    15 filings under 8-K 5.02 in 3 years

    0101420+

    CEOs: Shacey Petrovic, James Hollingshead, Ashley McEvoy

    04th
    Detail

    CEOs in the pay table: Shacey Petrovic, James Hollingshead, Ashley McEvoy. 15 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.

  • Flag

    Are the books clean?

    Red flags on file

    Since 2021

    • 0Restated
    • 2Auditor changes
    • 0Late filings
    • 010-K amended
    152nd
    Detail

    2 auditor changes (8-K 4.01) since 2021.

  • Reading the scores

    Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.

    Hover a chart for its figures. Detail has the full reading.

Pay versus performance

From the proxy statement filed April 6, 2026.

CEO pay as reportedActually paid ⓘWhat $100 becamePeer group the company chose
$0$16.4m$32.7m$10020212022202320242025$111$99

Pay tied most to Adjusted revenue

Other key measuresAdjusted RevenueAdjusted EBITRelative TSR

Show the figures
Fiscal yearCEOCEO payActually paidOther executives (avg)$100 becamePeersNet income
2025Ashley McEvoy, James Hollingshead$18.9m$25.2m$3.8m$111$99$247.1m
2024James Hollingshead$13.3m$32.7m$3.3m$102$81$418.3m
2023James Hollingshead$12.4m$12.8m$2.8m$85$82$206.3m
2022James Hollingshead, Shacey Petrovic$15.7m$16.1m$3.4m$115$77$4.6m
2021Shacey Petrovic$9.7m$9.1m$2.6m$104$96$16.8m

Insiders and the CEO's stakeBuying

President and CEO
Ashley McEvoy
Shares held
23,731
At that filing's price
≈ $3.5m
Latest Form 4
Aug 21, 2026

3 insiders bought $1.1m on the open market in the last six months, with their own money, near the lows. Sales: $60k.

Open-market trades by officers and directors since May 21, 2026.

  • BoughtElizabeth H WeathermanDirector$497kJun 3, 2026
  • BoughtTimothy C. StonesiferDirector$400kJun 3, 2026
  • BoughtAshley McEvoyPresident and CEO$162kAug 21, 2026
  • SoldLuciana BorioDirector$60kJun 3, 2026

Leadership and governance on file

20222023202420252026Leadership 23Red flags 2Votes 5
All 25 filings

Latest shareholder vote results: May 21, 2026, including the say-on-pay vote.

Where the money went

2021–2025: $59.6m returned to owners in buybacks and dividends, 7% of net income, and $255.7m of pay in stock.

Net incomeBuybacksDividendsStock-based payDiluted shares
$0$209.2m$418.3m20212022202320242025Shares69m70m74m74m72m
Show the figures
Fiscal year20212022202320242025
Revenue$1.0bn$1.1bn$1.7bn$2.1bn$2.7bn
Net income$16.8m$4.6m$206.3m$418.3m$247.1m
Stock-based pay$34.4m$40.9m$48.4m$69.3m$62.7m
Buybacks——$0$0$59.6m
Dividends—————
Diluted shares69m70m74m74m72m

Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.